News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Should And Would Amgen (AMGN) Break Itself Up?



4/24/2014 8:14:24 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

In the wake of yesterday’s pharma-deal madness (Novartis NVS -2.76% swapping assets with GlaxoSmithKline GSK +0.34% and selling its animal health division to Eli Lilly; Valeant and Bill Ackman making a hostile bid for Botox-maker Allergan AGN -0.79%), Bernstein analyst Geoffrey Porges sent a note out to investors asking what it might all mean for biotech stocks.

Hey, check out all the research scientist jobs. Post your resume today!

Read at Forbes


comments powered by Disqus
Forbes
Amgen
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES